4//SEC Filing
Hykes Andrew 4
Accession 0001127602-24-029927
CIK 0001531048other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 7:18 PM ET
Size
9.8 KB
Accession
0001127602-24-029927
Insider Transaction Report
Form 4
Hykes Andrew
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-20$55.65/sh−600$33,390→ 439,310 total - Sale
Common Stock
2024-12-20$55.20/sh−2,400$132,480→ 439,910 total
Holdings
- 1,550(indirect: By Children)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
- 1,550(indirect: By Children)
Common Stock
- 1,550(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $54.56 to $55.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $55.56 to $55.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Inari Medical, Inc.
CIK 0001531048
Entity typeother
Related Parties
1- filerCIK 0001806431
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 7:18 PM ET
- Size
- 9.8 KB